159 related articles for article (PubMed ID: 17287336)
1. Deletion of fetA gene sequences in serogroup B and C Neisseria meningitidis isolates.
Marsh JW; O'Leary MM; Shutt KA; Harrison LH
J Clin Microbiol; 2007 Apr; 45(4):1333-5. PubMed ID: 17287336
[TBL] [Abstract][Full Text] [Related]
2. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.
Harrison LH; Shutt KA; Schmink SE; Marsh JW; Harcourt BH; Wang X; Whitney AM; Stephens DS; Cohn AA; Messonnier NE; Mayer LW
J Infect Dis; 2010 Apr; 201(8):1208-24. PubMed ID: 20199241
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil.
Weidlich L; Baethgen LF; Mayer LW; Moraes C; Klein CC; Nunes LS; Rios Sda S; Kmetzsch CI; Rossetti ML; Zaha A
J Infect; 2008 Oct; 57(4):324-31. PubMed ID: 18814914
[TBL] [Abstract][Full Text] [Related]
4. Genotypic characterization of Neisseria meningitidis serogroup B strains circulating in China.
Yang L; Shao Z; Zhang X; Xu L; Peng J; Xu X; Liang X; Qi Y; Jin Q
J Infect; 2008 Mar; 56(3):211-8. PubMed ID: 18215423
[TBL] [Abstract][Full Text] [Related]
5. PorA variable antigenic regions VR1, VR2, and VR3 of Neisseria meningitidis serogroups B and C isolated in Brazil from 1999 to 2004.
de Filippis I; de Andrade CF; Silva L; Prevots DR; Vicente AC
Infect Immun; 2007 Jul; 75(7):3683-5. PubMed ID: 17502397
[TBL] [Abstract][Full Text] [Related]
6. Deletion of the meningococcal fetA gene used for antigen sequence typing of invasive and commensal isolates from Germany: frequencies and mechanisms.
Claus H; Elias J; Meinhardt C; Frosch M; Vogel U
J Clin Microbiol; 2007 Sep; 45(9):2960-4. PubMed ID: 17626167
[TBL] [Abstract][Full Text] [Related]
7. Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines.
Rojas E; Hoyos J; Oldfield NJ; Lee P; Flint M; Jones CH; Ala'Aldeen DA; Jansen KU; Anderson AS
PLoS One; 2015; 10(7):e0132140. PubMed ID: 26147212
[TBL] [Abstract][Full Text] [Related]
8. Consecutive use of two multiplex PCR-based assays for simultaneous identification and determination of capsular status of nine common Neisseria meningitidis serogroups associated with invasive disease.
Bennett DE; Cafferkey MT
J Clin Microbiol; 2006 Mar; 44(3):1127-31. PubMed ID: 16517911
[TBL] [Abstract][Full Text] [Related]
9. Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.
Bai X; Borrow R
Expert Rev Vaccines; 2010 Oct; 9(10):1203-17. PubMed ID: 20923270
[TBL] [Abstract][Full Text] [Related]
10. Rates of detection of Neisseria meningitidis in tonsils differ in relation to local incidence of invasive disease.
Greiner O; Berger C; Day PJ; Meier G; Tang CM; Nadal D
J Clin Microbiol; 2002 Nov; 40(11):3917-21. PubMed ID: 12409352
[TBL] [Abstract][Full Text] [Related]
11. Antigen sequence typing of outer membrane protein (fetA) gene of Neisseria meningitidis serogroup A from Delhi & adjoining areas.
Dwivedi S; Das BK; Kapil A; Sood S; Chaudhry R; Gupta S; Deb M; Nair D; Aneja S
Indian J Med Res; 2014 Dec; 140(6):766-9. PubMed ID: 25758575
[TBL] [Abstract][Full Text] [Related]
12. Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-MenC conjugate vaccine era, 2009-2013.
Tsang RS; Hoang L; Tyrrell G; Horsman G; Wylie J; Jamieson FB; Lefebvre B; Taha MK
J Med Microbiol; 2015 Feb; 64(Pt 2):174-9. PubMed ID: 25627205
[TBL] [Abstract][Full Text] [Related]
13. Variation of the factor H-binding protein of Neisseria meningitidis.
Brehony C; Wilson DJ; Maiden MCJ
Microbiology (Reading); 2009 Dec; 155(Pt 12):4155-4169. PubMed ID: 19729409
[TBL] [Abstract][Full Text] [Related]
14. [Neisseria meningitidis: characterisation and epidemiology].
Raymond J
Arch Pediatr; 2012 Sep; 19 Suppl 2():S55-60. PubMed ID: 22883367
[TBL] [Abstract][Full Text] [Related]
15. Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa.
Mothibeli KM; du Plessis M; von Gottberg A; Murphy E; Hoiseth SK; Zlotnick G; Klugman KP
Vaccine; 2011 Mar; 29(11):2187-92. PubMed ID: 21144918
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil.
de Filippis I; de Lemos AP; Hostetler JB; Wollenberg K; Sacchi CT; Dunning Hotopp JC; Harrison LH; Bash MC; Prevots DR
PLoS One; 2012; 7(3):e33016. PubMed ID: 22431994
[TBL] [Abstract][Full Text] [Related]
17. Antigenic shift and increased incidence of meningococcal disease.
Harrison LH; Jolley KA; Shutt KA; Marsh JW; O'Leary M; Sanza LT; Maiden MC;
J Infect Dis; 2006 May; 193(9):1266-74. PubMed ID: 16586364
[TBL] [Abstract][Full Text] [Related]
18. PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccine.
Sorhouet Pereira C; Regueira M; Mollerach M
J Med Microbiol; 2008 Mar; 57(Pt 3):338-342. PubMed ID: 18287297
[TBL] [Abstract][Full Text] [Related]
19. Assessment of vaccine potential of the Neisseria-specific protein NMB0938.
Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D
Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688
[TBL] [Abstract][Full Text] [Related]
20. The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease.
Kugelberg E; Gollan B; Farrance C; Bratcher H; Lucidarme J; Ibarz-Pavón AB; Maiden MC; Borrow R; Tang CM
PLoS One; 2010 Feb; 5(2):e9413. PubMed ID: 20195528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
